Thrombolytic therapy on acute ST-segment elevation myocardial infarction during cardiopulmonary resuscitation:One case report
-
Abstract: Cardiac arrest(CA) is the most serious complication of acute ST-segment elevation myocardial infarction(STEMI), which requires immediate high-quality cardiopulmonary resuscitation(CPR). Intravenous thrombolytic therapy is a method of reperfusion therapy, and there have been few previous studies on thrombolytic therapy in patients with acute STEMI during CPR. We present a case of thrombolytic therapy on acute STEMI during CPR to improve clinical practice under this circumstance.
-
[1] Ibanez B,James S,Agewall S,et al.2017ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J].Eur Heart J,2018,39(2):119-177.
[2] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393.
[3] 殷晓伟,张秀平,何芳,等.超长心肺复苏后急性心肌梗死溶栓治疗2例[J].中国急救复苏与灾害医学杂志,2020,15(4):494-495.
[4] Steg PG,Bonnefoy E,Chabaud S,et al.Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty:data from the CAPTIM randomized clinical trial[J].Circulation,2003,108(23):2851-2856.
[5] 陈静雅,朱雁鸿.肺栓塞合并心搏骤停心肺复苏后成功溶栓1例体会[J].中国危重病急救医学,2011,23(11):693-694.
[6] 瑞替普酶在STEMI溶栓的治疗中国专家共识专家组.瑞替普酶在STEMI溶栓治疗的中国专家共识[J].中国心血管病研究,2011,9(10):721-727.
计量
- 文章访问数: 183
- PDF下载数: 25
- 施引文献: 0